The MEF2A gene and ischaemic heart disease in Ireland

Autor: Conway, B, Fogarty, D, McKeveney, P, Harty, J, Sinnamon, K, Horan, PG, Allen, AR, Hughes, AE, Patterson, CC, Spence, MS, McGlinchey, PG, Belton, C, McKeown, PP, Armstrong, DJ, McCausland, EMA, Lee, ASH, Quinn, A, McQuilkin, M, Wright, GD, Finch, MB, Black, RNA, Spence, M, Cuskelly, GJ, Ennis, CN, McCance, DR, Young, IS, Bell, PM, Hunter, SJ, McCarty, D, Courtney, CH, Mullan, B, Campbell, NPS, Wilson, CM, Tohill, M, Patterson, C, Stevens, AB, Muir, AR, Neill, J, Dougan, J, Adgey, AAJ

Publikováno v: The Ulster Medical Journal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmc_________::1c7d9b650643fad97e22e49ce3e021a6
http://europepmc.org/articles/PMC1891743

A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA).

Autor: Pang T; Dudley Group NHS Foundation Trust, Russells Hall Hospital, Dudley., Bain SC; Institute of Life Science, Swansea University Medical School, Swansea., Black RNA; Department of Endocrinology and Diabetes, Altnagelvin Hospital, Derry., Boyle JG; Glasgow Royal Infirmary, School of Medicine, University of Glasgow, Glasgow., Elliott J; Diabetes and Endocrine Department, Sheffield Teaching Hospitals, Sheffield., Holcombe A; North East Essex Diabetes Service, Suffolk GP Federation, Colchester., Lee KCS; Sanofi, Guildford., Mulligan C; Ulster Hospital, SE Trust, Belfast., Saunders L; pH Associates, Marlow., Yousseif A; Diabetes and Endocrine Department, Royal Free London NHS Foundation Trust, London, UK., Baxter M; Sanofi, Guildford.

Publikováno v: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2019 Jan; Vol. 36 (1), pp. 110-119. Date of Electronic Publication: 2018 Nov 16.